NOLC1 and colorectal cancer: Therefore, immune checkpoint blocking therapy offers a broad therapeutic prospect for patients with high expression of NOLC1 in advanced colorectal cancer (Msaouel et al. 2021; Lelliott et al. 2021; Chen et al. 2021a).